Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Publication Preview--Ahead of Print
    • Past Issue Archive
    • Case of the Week Archive
    • Classic Case Archive
    • Case of the Month Archive
    • COVID-19 Content and Resources
  • For Authors
  • About Us
    • About AJNR
    • Editors
    • American Society of Neuroradiology
  • Submit a Manuscript
  • Podcasts
    • Subscribe on iTunes
    • Subscribe on Stitcher
  • More
    • Subscribers
    • Permissions
    • Advertisers
    • Alerts
    • Feedback
  • Other Publications
    • ajnr

User menu

  • Subscribe
  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

  • Subscribe
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Publication Preview--Ahead of Print
    • Past Issue Archive
    • Case of the Week Archive
    • Classic Case Archive
    • Case of the Month Archive
    • COVID-19 Content and Resources
  • For Authors
  • About Us
    • About AJNR
    • Editors
    • American Society of Neuroradiology
  • Submit a Manuscript
  • Podcasts
    • Subscribe on iTunes
    • Subscribe on Stitcher
  • More
    • Subscribers
    • Permissions
    • Advertisers
    • Alerts
    • Feedback
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds
Research ArticleFunctional

Evolving Use of fMRI in Medicare Beneficiaries

S. Asnafi, R. Duszak, J.M. Hemingway, D.R. Hughes and J.W. Allen
American Journal of Neuroradiology November 2020, 41 (11) 1996-2000; DOI: https://doi.org/10.3174/ajnr.A6845
S. Asnafi
aFrom the Department of Radiology and Imaging Sciences (S.A., R.D., J.W.A.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for S. Asnafi
R. Duszak
aFrom the Department of Radiology and Imaging Sciences (S.A., R.D., J.W.A.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for R. Duszak
J.M. Hemingway
cHarvey L. Neiman Health Policy Institute (J.M.H., D.R.H.), Reston, Virginia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for J.M. Hemingway
D.R. Hughes
cHarvey L. Neiman Health Policy Institute (J.M.H., D.R.H.), Reston, Virginia
dSchool of Economics (D.R.H.), Georgia Institute of Technology, Atlanta, Georgia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for D.R. Hughes
J.W. Allen
aFrom the Department of Radiology and Imaging Sciences (S.A., R.D., J.W.A.)
bNeurology (J.W.A.), Emory University School of Medicine, Atlanta, Georgia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for J.W. Allen
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
Loading

Abstract

SUMMARY: Using the Medicare Physician-Supplier Procedure Summary Master File, we evaluated the evolving use of fMRI in Medicare fee-for-service beneficiaries from 2007 through 2017. Annual use rates (per 1,000,000 enrollees) increased from 17.7 to 32.8 through 2014 and have remained static since. Radiologists have remained the dominant specialty group from 2007 to 2017 (86.4% and 88.6% of all services, respectively), and the outpatient setting has remained the dominant place of service (65.4% and 65.4%, respectively).

ABBREVIATIONS:

CPT
Current Procedural Terminology
MEG
magnetoencephalography

First introduced in 1991 for mapping the visual cortex, fMRI relies on detecting small changes in the blood oxygen level–dependent MR imaging signal as a result of neuronal activity following specific tasks.1 Since its introduction, fMRI has been widely used in neuroimaging research and increasingly incorporated into clinical practice. Currently, fMRI has value in the neurosurgical planning of conditions such as brain tumors or epilepsy, diagnosis and management of Alzheimer disease, and better understanding of psychiatric conditions.2

In January 2007, three distinct Current Procedural Terminology (CPT) codes were introduced to report fMRI services.3 Several studies have examined changing use of various radiologic modalities and procedures across various time periods,4,5 but no similar study has been performed to assess the nationwide adoption of fMRI. Given the relatively new translation of fMRI into clinical practice and the possibility that the high costs of fMRI might not be adequately reimbursed by current payor schemes,6 such information could potentially inform clinical practice guidelines and payer-coverage decisions. For these reasons and focusing on Medicare beneficiaries, we aimed to investigate the use patterns of fMRI with regard to both specialty groups and places of service since the introduction of unique CPT codes.

MATERIALS AND METHODS

The Annual Medicare Physician-Supplier Procedure Summary Master File from 2007 through 2017 was obtained from the Centers for Medicare & Medicaid Services. These files contain aggregated, submitted national Part B Medicare claims for all beneficiaries in the traditional Medicare fee-for-service program. These data are classified by codes for procedures, places of service, and provider specialties, along with the number of services both billed and denied. Physician-Supplier Procedure Summary files include no individual patient, diagnosis, or other encounter-specific information. Thus, their use does not constitute human subject research, and no institutional review board oversight was required for this study.

For this study, fMRIs were identified using the following service-specific CPT codes: 70554, 70555, and 96020 (Table 1).3 Analysis was performed as previously described using SPSS Statistics 25.0 (IBM) and Excel 2016 (Microsoft).4,5,7 fMRI use rates were calculated per 1,000,000 Medicare enrollees per year. Provider specialties and sites of service were grouped using relevant Medicare codes (Table 2).

View this table:
  • View inline
  • View popup
Table 1:

CPT Codes for fMRI

View this table:
  • View inline
  • View popup
Table 2:

Site of service and specialty groups studied with the corresponding codes

RESULTS

Between 2007 and 2014, use rates for fMRI studies performed on Medicare fee-for-service beneficiaries increased 85% (from 17.7 to 32.8) but have since stabilized (32.8, 32.6, 32.7, and 33.3 from 2014 to 2017, respectively). In 2007, radiology was the dominant specialty group, with a rate of 15.3 (versus 2.4 for all other specialties), which has continued to be the case since (Fig 1). The specialties with the second and the third highest rates were neurology and neurosurgery, respectively, with considerable year-to-year variability. Radiology, neurology, and neurosurgery accounted for overall use rates of 280.4, 11.2, and 3.4, respectively, during the entire time period.

FIG 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIG 1.

Functional MR imaging use in Part B Medicare beneficiaries from 2007 to 2017 by physician specialty group. Radiology (70554 + 70555) refers to the total billing of fMRI by this specialty. Radiology (70554) refers only to the 70554 CPT code. All other specialties reflect total billing.

Separate analysis of the CPT codes billed by radiology showed that the code 70554 (test selection/administration not requiring physician or psychologist administration) billing rate increased from 12.3 in 2007 to 20.7 in 2017 (Fig 1). Code 70555 (requiring physician or psychologist administration) radiology billing also increased from 3.0 in 2007 to 8.8 in 2017 (Fig 1). Code 96020 must always be accompanied by code 70555 during billing, though 96020 may be billed by a separate provider. For radiology, the rate of billing 96020 was 0.25 in 2007 and 5.18 in 2017. From 2007 through 2017, the rate of billing 96020 for radiology was always lower than for code 70555. However, the percentage of cases in which code 70555 was billed with 96020 by radiology has increased from 2007 to 2017.

Most of the fMRI studies were performed in the outpatient (office, outpatient hospital, or independent clinic) setting, accounting for 65.4% in 2007 and 65.4% in 2017. The second and the third most common sites were inpatient hospital (31.1 in 2007 and 29.6 in 2017) and emergency department (3.1% in 2007, and 5.0% in 2017). fMRI use with regard to place of service is illustrated in Fig 2.

FIG 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIG 2.

Functional MR imaging use in Part B Medicare beneficiaries from 2007 to 2017 by place of a service group.

DISCUSSION

Using annual aggregate Medicare fee-for-service claims files for all years for which unique CPT code data were currently available, we studied nationwide use of fMRI and found an increased adoption in the first 7 years after CPT codes became available, with a plateau in use thereafter. fMRI has consistently been performed predominantly by radiologists and predominantly in the outpatient setting, not dissimilar to patterns previously described for nonfunctional brain CT and MR imaging.8

Preoperative planning is one of the widely accepted applications of fMRI, which is commonly used in brain tumor surgery and in surgical resection of epileptic foci for certain patients.2 A recent study on national trends in brain tumor management during a relatively similar time period to our study (2004 to 2015) reported a total of 464,856 brain and other nervous system cancers among patients with a median age of 60 years, with an overall 56% rate of surgical procedures performed.9 In that study, 260,317 surgical procedures were performed on patients with brain cancer during the 11-year period. Not every neurosurgical procedure for brain cancer requires preoperative fMRI. However, given the benefit of fMRI in selected patients10⇓-12 and the difference between this number of surgical studies performed and the 10,056 fMRI studies billed during the similar 10-year period of our study, there may be a gap between potential ideal and actual fMRI use rates. Moreover, the prevalence and incidence of primary brain tumors in the United States are thought to be rising due to a combination of an aging population and improved diagnosis and therapies.9,13 Thus, it may be expected that the rate of brain surgery for these tumors will increase as well, particularly because the extent of tumor resection positively correlates with improved patient outcomes,14 and the need for preoperative fMRI should also increase.

Despite the increase in the use rates of fMRI, it is possible that barriers exist to furthering expansion of fMRI services and that current levels of fMRI use among Medicare beneficiaries might not be meeting the population-level clinical needs. Decreasing Medicare reimbursement ($618 in 2007 to $455 in 2017 for CPT code 7055415) is potentially a factor leading to the slowing of fMRI adoption. In addition, competing technologies for presurgical evaluation of refractory focal epilepsy and functional brain mapping, such as magnetoencephalography (MEG), have also grown.16 Increased expertise in the field of clinical MEG might also contribute to blunting the curve of fMRI use in recent years. However, despite the accepted clinical value of MEG,17,18 its accessibility is still low, with only 21 clinical MEG sites in 14 states listed by the American Clinical MEG Society.19 Future comparisons of MEG use with fMRI trends as well as regional use of MEG and fMRI are warranted.

Another potential barrier to fMRI adoption is likely related to the hardware, software, level of experience, and dedicated time required for acquisition, postprocessing, and interpretation of this study. Not surprisingly, radiologists have consistently performed the major share of the fMRIs for Medicare beneficiaries, and have experienced the largest growth since the introduction of dedicated CPT codes. In contrast, other specialties billed a relatively small number of fMRI services and showed no increases in use with time. Considering that 3 of the 4 main applications of fMRI concern neurology and neurosurgery (presurgical planning in brain tumors and epilepsy, more precise study of the level of consciousness in altered level of consciousness, and in follow-up of patients with traumatic brain injury and stroke), it is expected that those specialists participated as well in the provision of fMRI services. A secondary clinical application of fMRI is in diagnosis and efficacy assessment of certain psychiatric disease treatments.20 We identified no cases of fMRI billed by psychiatrists, possibly reflecting the low rate at which psychiatrists perform any imaging services.

A separate analysis of the CPT codes in this study showed that for radiology, both the number of billings for 96020 and the percentage of cases of simultaneous billing of codes 70555 and 96020 have increased from 2007 to 2017. This increase suggests that radiologists have become more comfortable across time acting as the physician who selects and administers fMRI paradigms, in addition to interpreting these studies. Alternatively, this may reflect an increased awareness of correct CPT billing practices. Regardless, despite the overall increase in radiology billing of 96020, the rate of billing of this code has always been lower than the rate of 70555, indicating that other specialties continue to perform and bill fMRI in conjunction with radiologists. Another possibility is that radiologists are performing both roles but incorrectly billing Medicare for this service.

The clinical use of resting-state fMRI, which is performed without an explicit task, has been advocated recently.21⇓-23 Once standardized clinical protocols are established, the use of resting-state fMRI may drive increased overall use of fMRI. The currently available fMRI CPT codes assume that a task is administered and there is no separate CPT code for isolated resting-state fMRI at this time. Therefore, it is not currently possible to assess the use of resting-state fMRI using national databases, so the impact of resting-state fMRI on overall fMRI use cannot be determined at this time.

Our study has limitations similar to those in other studies investigating the changing use of physician services. Most important, we studied only Medicare fee-for-service enrollees. Thus, our findings cannot necessarily be generalized to the population more broadly. However, considering that on the basis of the Surveillance, Epidemiology, and End Results Program data, approximately 40% of new national cases of brain and central nervous system cancers are associated with the older-than-65-year age group,24 our findings are, nonetheless, quite relevant. Additionally, we were constrained because certain Medicare provider codes did not allow identification of specific provider specialties (these were grouped as “unidentified specialty”). Moreover, we were not able to compare our findings on fMRI use trends with those of other advanced imaging techniques such as diffusion tensor imaging because there are no separate CPT codes for them. Future studies would benefit from the inclusion of both private and public payers as well as a larger age range of patients, particularly because presurgical fMRI is also used in the pediatric population.

In summary, fMRI use among the Medicare beneficiary population has markedly increased between 2007 and 2014 but has since plateaued. In this population, fMRI is primarily performed by radiologists in the outpatient setting.

Footnotes

  • Disclosures: Richard Duszak—RELATED: Grant: Harvey L. Neiman Health Policy Institute.* Danny R. Hughes—RELATED: Grant: Harvey L. Neiman Health Policy Institute.* Jason W. Allen—UNRELATED: Grants/Grants Pending: NIH R21 NS114603 (PI); NIH R01 MH111682 (Co-I); Radiological Society of North America Resident Grant (Mentor/Co-I), Comments: Hemodynamics, Thrombosis, and Stroke Risk in Patients With Carotid Webs, Impact of Trauma Exposure on Critical Periods in Brain Development, Functional and Structural Brain Connectivity Alterations in Visual Vertigo Syndrome: A prospective MRI Study of Central Vestibular Impairment in Mild Traumatic Brain Injury.* *Money paid to the institution.

References

  1. 1.↵
    1. Ogawa S,
    2. Lee TM,
    3. Kay AR, et al
    . Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proc Natl Acad Sci U S A 1990;87:9868–72 doi:10.1073/pnas.87.24.9868 pmid:2124706
    Abstract/FREE Full Text
  2. 2.↵
    1. Matthews PM,
    2. Honey GD,
    3. Bullmore ET
    . Applications of fMRI in translational medicine and clinical practice. Nat Rev Neurosci 2006;7:732–44 doi:10.1038/nrn1929 pmid:16924262
    CrossRefPubMed
  3. 3.↵
    1. Hart J Jr.,
    2. Rao SM,
    3. Nuwer M
    . Clinical functional magnetic resonance imaging. Cogn Behav Neurol 2007;20:141–44 doi:10.1097/WNN.0b013e31812570e2 pmid:17846511
    CrossRefPubMed
  4. 4.↵
    1. Duszak R Jr.,
    2. Bilal N,
    3. Picus D, et al
    . Central venous access: evolving roles of radiology and other specialties nationally over two decades. J Am Coll Radiology 2013;10:603–12 doi:10.1016/j.jacr.2013.02.002
    CrossRefPubMed
  5. 5.↵
    1. Duszak R Jr.,
    2. Walls DG,
    3. Wang JM, et al
    . Expanding roles of nurse practitioners and physician assistants as providers of nonvascular invasive radiology procedures. J Am Coll Radiol 2015;12:284–89 doi:10.1016/j.jacr.2014.08.021 pmid:25444061
    CrossRefPubMed
  6. 6.↵
    1. Yousem DM
    . The economics of functional magnetic resonance imaging: clinical and research. Neuroimaging Clin N Am 2014;24:717–24 doi:10.1016/j.nic.2014.07.007 pmid:25441510
    CrossRefPubMed
  7. 7.↵
    1. Morris E,
    2. Duszak R Jr.,
    3. Sista AK, et al
    . National trends in inferior vena cava filter placement and retrieval procedures in the Medicare population over two decades. J Am Coll Radiol 2018;15:1080–86 doi:10.1016/j.jacr.2018.04.024 pmid:30028676
    CrossRefPubMed
  8. 8.↵
    1. Babiarz LS,
    2. Yousem DM,
    3. Parker L, et al
    . Utilization rates of neuroradiology across neuroscience specialties in the private office setting: who owns or leases the scanners on which studies are performed? AJNR Am J Neuroradiol 2012;33:43–48 doi:10.3174/ajnr.A2738 pmid:22033720
    Abstract/FREE Full Text
  9. 9.↵
    1. Garcia CR,
    2. Slone SA,
    3. Dolecek TA, et al
    . Primary central nervous system tumor treatment and survival in the United States, 2004–2015. J Neurooncol 2019;144:179–91 doi:10.1007/s11060-019-03218-8 pmid:31254264
    CrossRefPubMed
  10. 10.↵
    1. Al-Okaili RN,
    2. Krejza J,
    3. Wang S, et al
    . Advanced MR imaging techniques in the diagnosis of intraaxial brain tumors in adults Radiographics 2006;2(Suppl 1):S173–89 pmid:17050514
    PubMed
  11. 11.↵
    1. Brodbelt A
    . Clinical applications of imaging biomarkers, Part 2: the neurosurgeon’s perspective. Br J Radiol 2011;84(Spec No 2):S205–08 doi:10.1259/bjr/19282704 pmid:22433829
    Abstract/FREE Full Text
  12. 12.↵
    1. Mabray MC,
    2. Barajas RF Jr.,
    3. Cha S
    . Modern brain tumor imaging. Brain Tumor Res Treat 2015;3:8–23 doi:10.14791/btrt.2015.3.1.8 pmid:25977902
    CrossRefPubMed
  13. 13.↵
    1. Feigin VL,
    2. Abajobir AA,
    3. Abate KH, et al
    . Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol 2017;16:877–97 doi:10.1016/S1474-4422(17)30299-5 pmid:28931491
    CrossRefPubMed
  14. 14.↵
    1. Sanai N,
    2. Berger MS
    . Glioma extent of resection and its impact on patient outcome. Neurosurgery 2008;62:753–64; discussion 264-66 doi:10.1227/01.neu.0000318159.21731.cf pmid:18496181
    CrossRefPubMed
  15. 15.↵
    Center for Medicare & Medicaid Services. Medicare Physician Fee Schedule (MPFS). https://www.cms.gov/apps/physician-fee-schedule/overview.aspx. Accessed June 10, 2020
  16. 16.↵
    1. Bagic A,
    2. Funke ME,
    3. Ebersole J
    ; ACMEGS Position Statement Committee. American Clinical MEG Society (ACMEGS) position statement: the value of magnetoencephalography (MEG)/magnetic source imaging (MSI) in noninvasive presurgical evaluation of patients with medically intractable localization-related epilepsy. J Clin Neurophysiol 2009;26:290–93 doi:10.1097/WNP.0b013e3181b49d50 pmid:19602984
    CrossRefPubMed
  17. 17.↵
    1. RamachandranNair R,
    2. Otsubo H,
    3. Shroff MM, et al
    . MEG predicts outcome following surgery for intractable epilepsy in children with normal or nonfocal MRI findings. Epilepsia 2007;48:149–57 doi:10.1111/j.1528-1167.2006.00901.x pmid:17241222
    CrossRefPubMed
  18. 18.↵
    1. Knowlton RC,
    2. Shih J
    . Magnetoencephalography in epilepsy. Epilepsia 2004;45(Suppl 4):61–71 doi:10.1111/j.0013-9580.2004.04012.x pmid:15281961
    CrossRefPubMed
  19. 19.↵
    American Clinical MEG Society. Clinical MEG Locations. https://www.acmegs.org/membership/clinical-meg-locations. Accessed June 9, 2020
  20. 20.↵
    1. Greicius MD,
    2. Srivastava G,
    3. Reiss AL, et al
    . Default-mode network activity distinguishes Alzheimer’s disease from healthy aging: evidence from functional MRI. Proc Natl Acad Sci USA 2004;101:4637–42 doi:10.1073/pnas.0308627101 pmid:15070770
    Abstract/FREE Full Text
  21. 21.↵
    1. Lee MH,
    2. Smyser CD,
    3. Shimony JS
    . Resting-state fMRI: a review of methods and clinical applications. AJNR Am J Neuroradiol 2013;34:1866–72 doi:10.3174/ajnr.A3263 pmid:22936095
    Abstract/FREE Full Text
  22. 22.↵
    1. Lee MH,
    2. Miller-Thomas MM,
    3. Benzinger TL, et al
    . Clinical resting-state fMRI in the preoperative setting: are we ready for prime time? Top Magn Reson Imaging 2016;25:11–18 doi:10.1097/RMR.0000000000000075 pmid:26848556
    CrossRefPubMed
  23. 23.↵
    1. Greicius M
    . Resting-state functional connectivity in neuropsychiatric disorders. Curr Opin Neurol 2008;21:424–30 doi:10.1097/WCO.0b013e328306f2c5 pmid:18607202
    CrossRefPubMed
  24. 24.↵
    National Cancer Institute. Cancer Stat Facts: Brain and Other Nervous System Cancer. https://seer.cancer.gov/statfacts/html/brain.html. Accessed January 20, 2020
  • Received April 9, 2020.
  • Accepted after revision June 22, 2020.
  • © 2020 by American Journal of Neuroradiology
PreviousNext
Back to top

In this issue

American Journal of Neuroradiology: 41 (11)
American Journal of Neuroradiology
Vol. 41, Issue 11
1 Nov 2020
  • Table of Contents
  • Index by author
  • Complete Issue (PDF)
Advertisement
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Evolving Use of fMRI in Medicare Beneficiaries
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Evolving Use of fMRI in Medicare Beneficiaries
S. Asnafi, R. Duszak, J.M. Hemingway, D.R. Hughes, J.W. Allen
American Journal of Neuroradiology Nov 2020, 41 (11) 1996-2000; DOI: 10.3174/ajnr.A6845

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Evolving Use of fMRI in Medicare Beneficiaries
S. Asnafi, R. Duszak, J.M. Hemingway, D.R. Hughes, J.W. Allen
American Journal of Neuroradiology Nov 2020, 41 (11) 1996-2000; DOI: 10.3174/ajnr.A6845
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Purchase

Jump to section

  • Article
    • Abstract
    • ABBREVIATIONS:
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Crossref
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

More in this TOC Section

  • Phenotyping Superagers Using Resting-State fMRI
  • Identification of the Language Network from Resting-State fMRI in Patients with Brain Tumors: How Accurate Are Experts?
  • Reconstruction of the Corticospinal Tract in Patients with Motor-Eloquent High-Grade Gliomas Using Multilevel Fiber Tractography Combined with Functional Motor Cortex Mapping
Show more Functional

Similar Articles

Advertisement

News and Updates

  • Lucien Levy Best Research Article Award
  • Thanks to our 2022 Distinguished Reviewers
  • Press Releases

Resources

  • Evidence-Based Medicine Level Guide
  • How to Participate in a Tweet Chat
  • AJNR Podcast Archive
  • Ideas for Publicizing Your Research
  • Librarian Resources
  • Terms and Conditions

Opportunities

  • Share Your Art in Perspectives
  • Get Peer Review Credit from Publons
  • Moderate a Tweet Chat

American Society of Neuroradiology

  • Neurographics
  • ASNR Annual Meeting
  • Fellowship Portal
  • Position Statements

© 2023 by the American Society of Neuroradiology | Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire